Kailera Therapeutics — Valuation, Funding & Investors

We're still building this profile — here is what Pulse has covered.

Latest Pulse

Jul 7, 2026Biotech's IPO Window Reopens With Record DebutsA run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.→

Coverage Timeline

newest first

Jul 7, 2026IPOBiotech's IPO Window Reopens With Record Debuts$670M-$719M record biotech raises→

All Coverage

IPO· Jul 6, 2026

Biotech's IPO Window Reopens With Record Debuts

IPO$670M-$719M record biotech raises

Biotech's IPO Window Reopens With Record Debuts

A run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.

Jul 6, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics